[1] T ISHIZAKI. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.[J]. Molecular Pharmacology, 2000, 57 5: 976-983.
[2] KALAMEGAM GAUTHAMAN Ariff B Chui Yee Fong. Effect of ROCK inhibitor Y-27632 on normal and variant human embryonic stem cells (hESCs) in vitro: its benefits in hESC expansion.[J]. Stem Cell Reviews and Reports, 2010, 6 1: 86-95. DOI:
10.1007/s12015-009-9107-8[3] XIANGYUN LI. The ROCK inhibitor Y-27632 enhances the survival rate of human embryonic stem cells following cryopreservation.[J]. Stem cells and development, 2008, 17 6: 1079-1085. DOI:
10.1089/scd.2007.0247[4] JEAN-DAVID MOREL. Proteomics Reveals Scope of Mycolactone-mediated Sec61 Blockade and Distinctive Stress Signature.[J]. Molecular & cellular proteomics : MCP, 2018: 1750-1765. DOI:
10.1074/mcp.ra118.000824[5] M. YAMAZAKI H M H Fujie. Chromatin condensation retains the osteogenic transcription factor, RUNX2, in the nucleus of human mesenchymal stem cells[J]. Journal of Biomechanical Science and Engineering, 1900, 1 1. DOI:
10.1299/jbse.20-00083